The production of IL- 1β from glioma cells is responsible for the activation of TLR-4 and overexpression of HMGB1, which most likely gives rise to HLA-G, contributing to glioma immune evasion response [95,96]. This evidence concerns the gene HLA-G and central nervous system cancer.